Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1033620110380040222
Clinical and Experimental Reproductive Medicine
2011 Volume.38 No. 4 p.222 ~ p.227
Serum anti-Mullerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis
Yoo Ji-Hee

Cha Sun-Hwa
Park Chan-Woo
Kim Jin-Young
Yang Kwang-Moon
Song In-Ok
Koong Mi-Kyoung
Kang Inn-Soo
Kim Hye-Ok
Abstract
Objective: To evaluate the ability of serum anti-Mullerian hormone (AMH), FSH, and age to clinically predict ovarian response to controlled ovarian hyperstimulation (COH) in IVF patients with endometriosis.

Methods: We evaluated 91 COH cycles, including 43 cycles with endometriosis (group I) and 48 cycles with male factor infertility (group II) from January to December, 2010. Patients were classified into study groups based on their surgical history of endometriosis-group Ia (without surgical history, n=16), group Ib (with a surgical history, n=27).

Results: The mean age was not significantly different between group I and group II. However, AMH and FSH were significantly different between group I and group II (1.9¡¾1.9 ng/mL vs. 4.1¡¾2.9 ng/mL, p<0.01; 13.1¡¾7.2 mIU/mL vs. 8.6¡¾3.3 mIU/mL, p<0.01). Furthermore, the number of retrieved oocytes and the number of matured oocytes were significantly lower in group I than in group II. In group II, AMH and FSH as well as age were significant predictors of retrieved oocytes on univariate analysis. Only the serum AMH level was a significant predictor of poor ovarian response in women with endometriosis.

Conclusion: Serum AMH may be a better predictor of the ovarian response of COH in patients with endometriosis than basal FSH or age. AMH level can be considered a useful clinical predictor of poor ovarian response in endometriosis patients.
KEYWORD
Anti-Mullerian hormone (Mullerian inhibiting substance), Ovarian stimulation, Endometriosis, In vitro fertilization, Intracytoplasmic sperm injection, Human
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø